| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2009-11-30 15:51:45 UTC |
|---|
| Update Date | 2023-02-21 17:17:57 UTC |
|---|
| HMDB ID | HMDB0013253 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | N-Acetylhistamine |
|---|
| Description | N-Acetylhistamine is a 4-(beta-Acetylaminoethyl)imidazole that is an intermediate in Histidine metabolism. It is generated from Histamine via the enzyme Transferases (EC 2.3.1.-). Histamine is an amine derived by enzymatic decarboxylation of histidine. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. |
|---|
| Structure | InChI=1S/C7H11N3O/c1-6(11)9-3-2-7-4-8-5-10-7/h4-5H,2-3H2,1H3,(H,8,10)(H,9,11) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(2-Acetamidoethyl)imidazole | ChEBI | | 4-(2-Acetylaminoethyl)imidazole | ChEBI | | 4-(beta-Acetylaminoethyl)imidazole | ChEBI | | alpha-N-Acetylhistamine | ChEBI | | N-[2-(1H-IMIDAZOL-4-yl)ethyl]acetamide | ChEBI | | Nalpha-acetylhistamine | ChEBI | | Nomega-acetylhistamine | ChEBI | | Omega-N-acetylhistamine | ChEBI | | 4-(b-Acetylaminoethyl)imidazole | Generator | | 4-(Β-acetylaminoethyl)imidazole | Generator | | a-N-Acetylhistamine | Generator | | Α-N-acetylhistamine | Generator | | Acetamide, N-(2-(1H-imidazol-4-yl)ethyl)- (9ci) | HMDB | | Acetamide, N-(2-imidazol-4-ylethyl)- (8ci) | HMDB | | Acetamide, {n-[2-(1H-imidazol-4-yl)ethyl]-} | HMDB | | Acetylhistamine | HMDB | | AHN | HMDB | | Imidazole C-4(5) deriv. 1 | HMDB | | N'-acetylhistamine | HMDB | | N-(2-(1H-Imidazol-4-yl)ethyl)acetamide | HMDB | | N-(2-(1H-Imidazol-4-yl)ethyl)acetamide (acd/name 4.0) | HMDB | | N-(2-(Imidazol-4-yl)ethyl)acetamide | HMDB | | N-(2-Imidazol-4-ylethyl)-acetamide | HMDB | | N-.Omega.-acetylhistamine | HMDB | | N-Omega-acetyl-histamine | HMDB | | N-Omega-acetylhistamine | HMDB | | N-[2-(1H-Imidazol-4-yl)ethyl]-acetamide | HMDB | | N-[2-(3H-Imidazol-4-yl)ethyl]acetamide | HMDB | | N-Acetylhistamine | KEGG |
|
|---|
| Chemical Formula | C7H11N3O |
|---|
| Average Molecular Weight | 153.1817 |
|---|
| Monoisotopic Molecular Weight | 153.090211989 |
|---|
| IUPAC Name | N-[2-(1H-imidazol-5-yl)ethyl]acetamide |
|---|
| Traditional Name | N-acetylhistamine |
|---|
| CAS Registry Number | 673-49-4 |
|---|
| SMILES | CC(=O)NCCC1=CN=CN1 |
|---|
| InChI Identifier | InChI=1S/C7H11N3O/c1-6(11)9-3-2-7-4-8-5-10-7/h4-5H,2-3H2,1H3,(H,8,10)(H,9,11) |
|---|
| InChI Key | XJWPISBUKWZALE-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-acetyl-2-arylethylamines. N-acetyl-2-arylethylamines are compounds containing an acetamide group that is N-linked to an arylethylamine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Carboxylic acid derivatives |
|---|
| Direct Parent | N-acetyl-2-arylethylamines |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-acetyl-2-arylethylamine
- Azole
- Imidazole
- Heteroaromatic compound
- Secondary carboxylic acid amide
- Organoheterocyclic compound
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 8408 mg/L @ 25 °C (est) | The Good Scents Company Information System | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.16 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 8.4333 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 5.86 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 204.1 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 407.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 272.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 63.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 167.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 45.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 259.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 239.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 696.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 562.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 38.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 753.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 180.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 187.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 519.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 403.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 215.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-Acetylhistamine,1TMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C | 1715.1 | Semi standard non polar | 33892256 | | N-Acetylhistamine,1TMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C | 1834.0 | Standard non polar | 33892256 | | N-Acetylhistamine,1TMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C | 2259.5 | Standard polar | 33892256 | | N-Acetylhistamine,1TMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C | 1824.3 | Semi standard non polar | 33892256 | | N-Acetylhistamine,1TMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C | 1736.6 | Standard non polar | 33892256 | | N-Acetylhistamine,1TMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C | 2352.4 | Standard polar | 33892256 | | N-Acetylhistamine,2TMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 1815.5 | Semi standard non polar | 33892256 | | N-Acetylhistamine,2TMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 1901.3 | Standard non polar | 33892256 | | N-Acetylhistamine,2TMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 2077.1 | Standard polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 1910.1 | Semi standard non polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 2071.2 | Standard non polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #1 | CC(=O)N(CCC1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 2369.3 | Standard polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C(C)(C)C | 2092.2 | Semi standard non polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C(C)(C)C | 1957.9 | Standard non polar | 33892256 | | N-Acetylhistamine,1TBDMS,isomer #2 | CC(=O)NCCC1=CN=CN1[Si](C)(C)C(C)(C)C | 2427.4 | Standard polar | 33892256 | | N-Acetylhistamine,2TBDMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2276.2 | Semi standard non polar | 33892256 | | N-Acetylhistamine,2TBDMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2327.9 | Standard non polar | 33892256 | | N-Acetylhistamine,2TBDMS,isomer #1 | CC(=O)N(CCC1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2244.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - N-Acetylhistamine GC-MS (2 TMS) | splash10-0uxr-3900000000-d8ae05cd513aafb1e8b8 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - N-Acetylhistamine GC-MS (Non-derivatized) | splash10-0uxr-3900000000-d8ae05cd513aafb1e8b8 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - N-Acetylhistamine GC-EI-TOF (Non-derivatized) | splash10-014i-0900000000-2dfb1ae92e261d890924 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylhistamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-003u-9200000000-c2cd0a732f2c5054c24d | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylhistamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylhistamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , negative-QTOF | splash10-0udi-0900000000-d0bc73206be68067f9a5 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , negative-QTOF | splash10-03di-0900000000-835331e6a6b0dc9ff0bb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , negative-QTOF | splash10-03di-4900000000-57a127cb56f0680d010c | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , negative-QTOF | splash10-001i-9200000000-0b6fc56d8ae42e3e9d68 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , negative-QTOF | splash10-001i-9000000000-e259ccc99fabcad89477 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , positive-QTOF | splash10-0udi-0900000000-27c24608d70cabc3f3be | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , positive-QTOF | splash10-0002-9500000000-f695664eaae1501afed2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , positive-QTOF | splash10-0002-9000000000-2ac0af2751c6c863cf8b | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , positive-QTOF | splash10-0002-9000000000-8063da1e33f922c07a87 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine LC-ESI-QQ , positive-QTOF | splash10-014j-9000000000-fba02d7e1796abce7418 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 10V, Positive-QTOF | splash10-0002-9700000000-e9275a5f9b9bfd4fa339 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 30V, Positive-QTOF | splash10-0002-9000000000-2e4192f9db4adb25cbe7 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 0V, Positive-QTOF | splash10-0udi-2900000000-9cce9f1ebcda40f2f0df | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 35V, Positive-QTOF | splash10-0002-9200000000-636d6bfe4e0886f5fe85 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 0V, Positive-QTOF | splash10-0udi-1900000000-bfb58634d27518bf23c4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 10V, Positive-QTOF | splash10-0002-9600000000-0ade06e0ddc403d2ba23 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 10V, Positive-QTOF | splash10-0f6t-8900000000-98c9eea3bd9e72514a9c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 30V, Positive-QTOF | splash10-0002-9000000000-ab0bdee2f1ac65414e40 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylhistamine 30V, Negative-QTOF | splash10-001i-9200000000-b9a62e0f9ec59ff00801 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 10V, Positive-QTOF | splash10-0ik9-1900000000-5311bce7d65a52133abd | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 20V, Positive-QTOF | splash10-03di-9700000000-63ea38d6f6a6d3615d9a | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 40V, Positive-QTOF | splash10-015d-9000000000-6f330be8167d7f408e1d | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 10V, Negative-QTOF | splash10-0udi-1900000000-5422a39dc096efcd42eb | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 20V, Negative-QTOF | splash10-0nn9-7900000000-0c01f02bfbb10b61d801 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylhistamine 40V, Negative-QTOF | splash10-052f-9000000000-b8d5d859032983134900 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|